LUMO(Delisted)
Lumos PharmaยทNASDAQ
--
--(--)
LUMO fundamentals
Lumos Pharma (LUMO) released its earnings on Nov 2, 2017: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Nov 2, 2017
EPS
Revenue
Revenue & Expenses
LUMO has released its 2024 Q3 earnings report, with revenue of 726.00K, reflecting a YoY change of 10271.43%, and net profit of -7.47M, showing a YoY change of 10.04%. The Sankey diagram below clearly presents LUMO's revenue sources and cost distribution.
Key Indicators
Lumos Pharma (LUMO) key financial stats and ratios, covering profitability, financial health, and leverage.
Lumos Pharma (LUMO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Lumos Pharma (LUMO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Lumos Pharma (LUMO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Lumos Pharma (LUMO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Lumos Pharma (LUMO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
